Form 4: Quipt Home Medical CEO Exercises Stock Options

Quipt Home Medical Corp. CEO Gregory John Crawford exercised options to acquire 583,500 common shares at $1.11 per share, increasing his direct and indirect beneficial ownership.

Summary

• Gregory John Crawford, President/CEO and Director of Quipt Home Medical Corp. (QIPT), reported transactions on December 5, 2025.
• Crawford acquired 581,000 common shares directly through the exercise of derivative securities (options).
• An additional 2,500 common shares were acquired indirectly by his spouse through the exercise of options.
• The exercise price for these options was $1.11 per share, converted from 1.50 Canadian dollars at a rate of 0.74 United States dollars per Canadian dollar.
• All options exercised were fully vested as of October 1, 2024.
• Following these transactions, Crawford directly beneficially owns 3,351,196 common shares.
• Indirect beneficial ownership includes 22,500 common shares by his spouse and 1,216,832 common shares by the Gregory J. Crawford Family 2017 Children's Trust.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The exercise of options by the CEO and a director, especially under a 10b5-1 plan, generally indicates confidence in the company's future. While not a direct 'buy' signal, it's a positive indicator of insider alignment with shareholder interests.

Positives

• Increased insider ownership by the CEO, which can signal confidence in the company's future prospects.
• The exercise of options indicates a conversion of potential equity into actual equity, aligning management's interests with shareholders.
• The transaction was conducted under a Rule 10b5-1(c) plan, suggesting a pre-planned and systematic approach to stock transactions.

Negatives

• The exercise price of $1.11 per share is a fixed historical price, not necessarily reflecting current market valuation.

Risks

• While not a direct risk from the filing, insider transactions, even under 10b5-1 plans, can sometimes be misinterpreted by the market.
• The value of the acquired shares is subject to market fluctuations.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is solely focused on reporting insider transactions.

Management Comments

• The exercise price for this award is denominated in Canadian dollars at 1.50. All these options have vested according to the award agreement and are, as of October 1, 2024, exercisable. Converted from Canadian dollars to United States dollars as of the date hereof at a conversion rate of 0.74 United States dollars per Canadian dollar.
• Shares are held by the Gregory J. Crawford Family 2017 Children's Trust for the benefit of Mr. Crawford's children. Mr. Crawford disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mr. Crawford is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
• The reporting person is reporting this transaction to reflect an option granted to the reporting person's spouse that was recently discovered. The reporting person was not previously aware of the option and is reporting it promptly upon discovery. The reporting person disclaims beneficial ownership of the securities held by the spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Industry Context

This filing is a routine insider transaction report and does not provide specific insights into broader industry trends or competitive landscape. However, insider buying or option exercises are generally viewed by the market as a sign of confidence from management in the company's future prospects within its sector, which for Quipt Home Medical Corp. is the home medical equipment and respiratory care industry.

Comparison to Industry Standards

• This filing reports an insider transaction, which is a standard disclosure requirement for public companies.
• There are no specific industry benchmarks for the volume or frequency of insider option exercises, as these are typically tied to individual compensation plans and personal financial decisions.
• The exercise price of $1.11 USD is specific to the terms of the options granted to Mr. Crawford and is not directly comparable to market prices or option terms of executives at other companies like ResMed Inc. (RMD) or Invacare Corporation (IVC) without detailed knowledge of their respective compensation structures and grant dates.

Corporate Governance

Related Party Transactions

• Acquisition of 2,500 common shares indirectly by the reporting person's spouse through option exercise, which was recently discovered and promptly reported.
• Beneficial ownership of 1,216,832 common shares by the Gregory J. Crawford Family 2017 Children's Trust, for which Mr. Crawford disclaims beneficial ownership.

Stakeholder Impact

• Shareholders: Increased alignment of the CEO's financial interests with shareholders due to increased direct and indirect equity ownership.
• Employees: No direct impact on employees mentioned in this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders mentioned in this filing.

Next Steps

• No specific future actions or milestones are mentioned in this Form 4 filing, as it is a historical report of a completed transaction.

Key Dates

Keywords

Quipt Home Medical Corp, QIPT, Form 4, Insider Transaction, Stock Options, CEO, Gregory John Crawford, Beneficial Ownership, Rule 10b5-1